APYX
Apyx Medical Corporation
Price Chart
Latest Quote
$4.47
+0.18 (+4.20%)
Current Price
| Previous Close | $4.29 |
| Open | $4.28 |
| Day High | $4.68 |
| Day Low | $4.24 |
| Volume | 317,804 |
Stock Information
| Shares Outstanding | 41.87M |
| Total Debt | $39.46M |
| Cash Equivalents | $31.14M |
| Revenue | $55.90M |
| Net Income | $-9.17M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $187.18M |
| EPS (TTM) | $-0.22 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $195.76M |
| Sales | $55.90M |
| Income | $-9.17M |
| Book/sh | $0.31 |
| Cash/sh | $0.74 |
| Employees | 205 |
Financial Ratios
| Quick Ratio | 4.65 |
| Current Ratio | 5.80 |
| Debt/Eq | 301.50 |
Returns & Margins
| ROA | -4.37% |
| ROE | -76.49% |
| Gross Margin | 63.15% |
| Operating Margin | -7.29% |
| Profit Margin | -16.40% |
Ownership
| Insider Ownership | 13.26% |
| Institutional Ownership | 49.71% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -17.03 |
| PEG | 0.59 |
| P/S | 3.35 |
| P/B | 14.61 |
Analyst Data
| Recommendation | none |
| Target Price | $6.50 |
Technical Indicators
| SMA20 | $4.02 |
| SMA50 | $3.80 |
| SMA200 | $3.43 |
| RSI | 58.40 |
| ATR | 0.3205 |
| Shares Float | 29.12M |
| Short Float | 0.42% |
| Short Ratio | 0.73 |
| Rel Volume | 1.70 |
Performance History
| Week | +11.89% |
| Month | +53.08% |
| Quarter | +43.27% |
| 6 Months | +11.75% |
| YTD | +27.71% |
| Year | +169.28% |
| 3 Years | -29.38% |
| 5 Years | -54.34% |
| 10 Years | -30.91% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $4.47 | 319,000 |
| 2026-06-04 | $4.29 | 535,100 |
| 2026-06-03 | $3.79 | 79,000 |
| 2026-06-02 | $3.85 | 112,800 |
| 2026-06-01 | $3.96 | 91,500 |
| 2026-05-29 | $3.99 | 110,600 |
| 2026-05-28 | $4.15 | 98,600 |
| 2026-05-27 | $3.90 | 75,500 |
| 2026-05-26 | $4.09 | 100,000 |
| 2026-05-22 | $4.13 | 127,500 |
| 2026-05-21 | $4.25 | 154,800 |
| 2026-05-20 | $3.79 | 150,500 |
| 2026-05-19 | $3.94 | 72,800 |
| 2026-05-18 | $3.87 | 158,700 |
| 2026-05-15 | $4.05 | 173,700 |
| 2026-05-14 | $4.36 | 411,600 |
| 2026-05-13 | $3.84 | 88,400 |
| 2026-05-12 | $4.09 | 213,600 |
| 2026-05-11 | $3.92 | 418,600 |
| 2026-05-08 | $3.67 | 256,800 |
| 2026-05-07 | $3.56 | 762,600 |
| 2026-05-06 | $2.92 | 399,600 |
About Apyx Medical Corporation
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
đ° Latest News
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals
Simply Wall St. âĸ 2026-06-01T14:05:51Z
What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play
Motley Fool âĸ 2026-05-21T23:05:33Z
Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth
Motley Fool âĸ 2026-05-21T22:45:13Z
What to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Year
Motley Fool âĸ 2026-05-21T22:28:44Z
This Satellite Company Grew Revenue 80%. One Fund Just Disclosed Buying $6 Million Worth of Shares
Motley Fool âĸ 2026-05-21T22:09:37Z
Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50
Simply Wall St. âĸ 2026-05-11T10:29:26Z
Apyx Medical (APYX) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-08T15:16:55Z
NewBeauty Award Win Keeps Attention on Apyx Medicalâs Renuvion Growth Strategy
InvestorsHub âĸ 2026-05-07T15:08:17Z
Apyx Medical Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T13:22:26Z
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-07T12:50:07Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $19,800,000 | $18,742,000 | $18,590,000 | $15,379,000 |
| Cost Of Revenue | $19,800,000 | $18,742,000 | $18,590,000 | $15,379,000 |
| Total Revenue | $52,844,000 | $48,102,000 | $52,349,000 | $44,510,000 |
| Operating Revenue | $52,844,000 | $48,102,000 | $52,349,000 | $44,510,000 |
| Expenses | ||||
| Interest Expense | $5,589,000 | $5,907,000 | $2,478,000 | $15,000 |
| Total Expenses | $59,290,000 | $66,947,000 | $72,300,000 | $68,072,000 |
| Other Income Expense | $92,000 | $-161,000 | $226,000 | $509,000 |
| Other Non Operating Income Expenses | $92,000 | $-161,000 | $622,000 | $509,000 |
| Net Non Operating Interest Income Expense | $-4,481,000 | $-4,301,000 | $-1,557,000 | $142,000 |
| Interest Expense Non Operating | $5,589,000 | $5,907,000 | $2,478,000 | $15,000 |
| Operating Expense | $39,490,000 | $48,205,000 | $53,710,000 | $52,693,000 |
| General And Administrative Expense | $36,117,000 | $43,125,000 | $48,270,000 | $48,149,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,211,000 | $-23,463,000 | $-18,713,000 | $-23,184,000 |
| Net Interest Income | $-4,481,000 | $-4,301,000 | $-1,557,000 | $142,000 |
| Interest Income | $1,108,000 | $1,606,000 | $921,000 | $157,000 |
| Normalized Income | $-11,211,000 | $-23,463,000 | $-18,362,144 | $-23,184,000 |
| Net Income From Continuing And Discontinued Operation | $-11,211,000 | $-23,463,000 | $-18,713,000 | $-23,184,000 |
| Total Operating Income As Reported | $-6,446,000 | $-18,845,000 | $-17,259,000 | $-23,562,000 |
| Net Income Common Stockholders | $-11,211,000 | $-23,463,000 | $-18,713,000 | $-23,184,000 |
| Net Income | $-11,211,000 | $-23,463,000 | $-18,713,000 | $-23,184,000 |
| Net Income Including Noncontrolling Interests | $-11,105,000 | $-23,559,000 | $-18,850,000 | $-23,278,000 |
| Net Income Continuous Operations | $-11,105,000 | $-23,559,000 | $-18,850,000 | $-23,278,000 |
| Pretax Income | $-10,835,000 | $-23,307,000 | $-21,282,000 | $-22,911,000 |
| Interest Income Non Operating | $1,108,000 | $1,606,000 | $921,000 | $157,000 |
| Operating Income | $-6,446,000 | $-18,845,000 | $-19,951,000 | $-23,562,000 |
| Gross Profit | $33,044,000 | $29,360,000 | $33,759,000 | $29,131,000 |
| Special Income Charges | - | $0 | $-396,000 | $0 |
| Per Share | ||||
| Diluted EPS | $-0.27 | $-0.66 | $-0.54 | $-0.67 |
| Basic EPS | $-0.27 | $-0.66 | $-0.54 | $-0.67 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-45,144 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,591,000 | $-16,801,000 | $-17,716,000 | $-22,006,000 |
| Reconciled Depreciation | $655,000 | $599,000 | $692,000 | $890,000 |
| EBITDA (Bullshit earnings) | $-4,591,000 | $-16,801,000 | $-18,112,000 | $-22,006,000 |
| EBIT | $-5,246,000 | $-17,400,000 | $-18,804,000 | $-22,896,000 |
| Diluted Average Shares | $41,095,000 | $35,542,000 | $34,622,000 | $34,516,000 |
| Basic Average Shares | $41,095,000 | $35,542,000 | $34,622,000 | $34,516,000 |
| Diluted NI Availto Com Stockholders | $-11,211,000 | $-23,463,000 | $-18,713,000 | $-23,184,000 |
| Minority Interests | $-106,000 | $96,000 | $137,000 | $94,000 |
| Tax Provision | $270,000 | $252,000 | $-2,432,000 | $367,000 |
| Research And Development | $3,373,000 | $5,080,000 | $5,440,000 | $4,544,000 |
| Selling General And Administration | $36,117,000 | $43,125,000 | $48,270,000 | $48,149,000 |
| Other Gand A | $22,106,000 | $25,772,000 | $29,229,000 | $29,528,000 |
| Salaries And Wages | $14,011,000 | $17,353,000 | $19,041,000 | $18,621,000 |
| Total Unusual Items | - | $0 | $-396,000 | $0 |
| Total Unusual Items Excluding Goodwill | - | $0 | $-396,000 | $0 |
| Other Special Charges | - | - | $396,000 | - |
Fetched: 2026-05-26
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $14,540,000 | $14,210,000 | $26,701,000 | $37,582,000 |
| Total Assets | $66,840,000 | $64,842,000 | $79,240,000 | $51,775,000 |
| Total Non Current Assets | $8,369,000 | $8,402,000 | $8,878,000 | $8,803,000 |
| Other Non Current Assets | $1,752,000 | $1,664,000 | $1,732,000 | $1,217,000 |
| Current Assets | $58,471,000 | $56,440,000 | $70,362,000 | $42,972,000 |
| Other Current Assets | $1,353,000 | $1,655,000 | $2,764,000 | $2,737,000 |
| Inventory | $8,602,000 | $7,564,000 | $9,923,000 | $11,797,000 |
| Receivables | $16,776,000 | $15,480,000 | $14,023,000 | $18,246,000 |
| Accounts Receivable | $16,776,000 | $15,480,000 | $14,023,000 | $10,602,000 |
| Allowance For Doubtful Accounts Receivable | $-1,020,000 | $-1,000,000 | $-608,000 | $-668,000 |
| Cash Cash Equivalents And Short Term Investments | $31,740,000 | $31,741,000 | $43,652,000 | $10,192,000 |
| Cash And Cash Equivalents | $31,740,000 | $31,741,000 | $43,652,000 | $10,192,000 |
| Other Receivables | - | - | $30,000 | $99,000 |
| Taxes Receivable | - | - | $0 | $7,545,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $3,109,000 | $2,152,000 | - | - |
| Total Debt | $39,340,000 | $38,764,000 | $38,501,000 | $796,000 |
| Long Term Debt And Capital Lease Obligation | $38,912,000 | $38,409,000 | $38,134,000 | $543,000 |
| Long Term Debt | $34,849,000 | $33,893,000 | $33,185,000 | - |
| Current Debt And Capital Lease Obligation | $428,000 | $355,000 | $367,000 | $253,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $52,009,000 | $50,507,000 | $52,318,000 | $13,982,000 |
| Total Non Current Liabilities Net Minority Interest | $40,309,000 | $39,786,000 | $39,578,000 | $2,132,000 |
| Other Non Current Liabilities | $347,000 | $259,000 | $198,000 | $181,000 |
| Non Current Deferred Liabilities | $1,050,000 | $1,118,000 | $1,246,000 | $1,408,000 |
| Current Liabilities | $11,700,000 | $10,721,000 | $12,740,000 | $11,850,000 |
| Current Deferred Liabilities | $643,000 | $693,000 | $488,000 | $853,000 |
| Payables And Accrued Expenses | $8,880,000 | $9,673,000 | $10,340,000 | $10,744,000 |
| Payables | $3,058,000 | $2,615,000 | $2,712,000 | $4,748,000 |
| Accounts Payable | $3,058,000 | $2,615,000 | $2,712,000 | $2,669,000 |
| Total Tax Payable | - | - | $0 | $2,079,000 |
| Other Current Liabilities | - | - | - | $2,079,000 |
| Equity | ||||
| Total Equity Gross Minority Interest | $14,831,000 | $14,335,000 | $26,922,000 | $37,793,000 |
| Stockholders Equity | $14,540,000 | $14,210,000 | $26,701,000 | $37,582,000 |
| Retained Earnings | $-89,122,000 | $-77,911,000 | $-54,448,000 | $-35,735,000 |
| Other | ||||
| Ordinary Shares Number | $41,785,946 | $37,793,886 | $34,643,888 | $34,597,822 |
| Share Issued | $41,785,946 | $37,793,886 | $34,643,888 | $34,597,822 |
| Tangible Book Value | $14,540,000 | $14,210,000 | $26,701,000 | $37,582,000 |
| Invested Capital | $49,389,000 | $48,103,000 | $59,886,000 | $37,582,000 |
| Working Capital | $46,771,000 | $45,719,000 | $57,622,000 | $31,122,000 |
| Capital Lease Obligations | $4,491,000 | $4,871,000 | $5,316,000 | $796,000 |
| Total Capitalization | $49,389,000 | $48,103,000 | $59,886,000 | $37,582,000 |
| Minority Interest | $291,000 | $125,000 | $221,000 | $211,000 |
| Additional Paid In Capital | $103,620,000 | $92,083,000 | $81,114,000 | $73,282,000 |
| Capital Stock | $42,000 | $38,000 | $35,000 | $35,000 |
| Common Stock | $42,000 | $38,000 | $35,000 | $35,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $1,050,000 | $1,118,000 | $1,246,000 | $1,408,000 |
| Long Term Capital Lease Obligation | $4,063,000 | $4,516,000 | $4,949,000 | $543,000 |
| Current Deferred Revenue | $643,000 | $693,000 | $488,000 | $853,000 |
| Current Capital Lease Obligation | $428,000 | $355,000 | $367,000 | $253,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,749,000 | $0 | $1,545,000 | $0 |
| Current Accrued Expenses | $5,822,000 | $7,058,000 | $7,628,000 | $5,996,000 |
| Net PPE | $6,617,000 | $6,738,000 | $7,146,000 | $7,586,000 |
| Accumulated Depreciation | $-4,293,000 | $-3,989,000 | $-3,522,000 | $-5,041,000 |
| Gross PPE | $10,910,000 | $10,727,000 | $10,668,000 | $12,627,000 |
| Leases | $361,000 | $281,000 | $212,000 | $178,000 |
| Construction In Progress | $162,000 | $635,000 | $400,000 | $507,000 |
| Other Properties | $5,395,000 | $5,713,000 | $6,154,000 | $1,672,000 |
| Machinery Furniture Equipment | $4,992,000 | $4,098,000 | $3,902,000 | $4,244,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-1,207,000 | $-1,032,000 | $-875,000 | $-457,000 |
| Finished Goods | $2,729,000 | $2,705,000 | $4,429,000 | $5,115,000 |
| Work In Process | $2,195,000 | $1,918,000 | $2,257,000 | $2,160,000 |
| Raw Materials | $4,885,000 | $3,973,000 | $4,112,000 | $4,979,000 |
| Buildings And Improvements | - | - | $0 | $4,426,000 |
| Land And Improvements | - | - | $0 | $1,600,000 |
Fetched: 2026-05-26
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,115,000 | $-18,769,000 | $-5,782,000 | $-21,290,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-8,001,000 | $-18,047,000 | $-5,249,000 | $-20,280,000 |
| Cash Flow From Continuing Operating Activities | $-8,001,000 | $-18,047,000 | $-5,249,000 | $-20,280,000 |
| Operating Gains Losses | $19,000 | $13,000 | $557,000 | $75,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,114,000 | $-722,000 | $-533,000 | $-1,010,000 |
| Investing Cash Flow | $-1,114,000 | $-722,000 | $6,734,000 | $-1,010,000 |
| Cash Flow From Continuing Investing Activities | $-1,114,000 | $-722,000 | $6,734,000 | $-1,010,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $9,300,000 | $7,000,000 | $0 | - |
| Financing Cash Flow | $9,580,000 | $6,745,000 | $32,166,000 | $217,000 |
| Cash Flow From Continuing Financing Activities | $9,580,000 | $6,745,000 | $32,166,000 | $217,000 |
| Net Other Financing Charges | $-188,000 | $-235,000 | $-2,959,000 | - |
| Net Common Stock Issuance | $9,300,000 | $7,000,000 | $0 | - |
| Common Stock Issuance | $9,300,000 | $7,000,000 | $0 | - |
| Other | ||||
| Repayment Of Debt | $-20,000 | $-20,000 | $-11,067,000 | $-148,000 |
| Interest Paid Supplemental Data | $4,636,000 | $4,746,000 | $1,935,000 | $15,000 |
| Income Tax Paid Supplemental Data | $258,000 | $382,000 | $329,000 | $128,000 |
| End Cash Position | $31,740,000 | $31,741,000 | $43,652,000 | $10,192,000 |
| Beginning Cash Position | $31,741,000 | $43,652,000 | $10,192,000 | $30,870,000 |
| Effect Of Exchange Rate Changes | $-466,000 | $113,000 | $-191,000 | $395,000 |
| Proceeds From Stock Option Exercised | $488,000 | $0 | $86,000 | $365,000 |
| Net Issuance Payments Of Debt | $-20,000 | $-20,000 | $35,039,000 | $-148,000 |
| Net Long Term Debt Issuance | $-20,000 | $-20,000 | $35,039,000 | $-148,000 |
| Long Term Debt Payments | $-20,000 | $-20,000 | $-11,067,000 | $-148,000 |
| Net PPE Purchase And Sale | $-1,114,000 | $-722,000 | $6,734,000 | $-1,010,000 |
| Purchase Of PPE | $-1,114,000 | $-722,000 | $-533,000 | $-1,010,000 |
| Change In Working Capital | $-1,591,000 | $-1,245,000 | $5,543,000 | $-5,217,000 |
| Change In Payables And Accrued Expense | $564,000 | $-2,330,000 | $301,000 | $-1,141,000 |
| Change In Accrued Expense | $209,000 | $-2,267,000 | $276,000 | $-1,208,000 |
| Change In Payable | $355,000 | $-63,000 | $25,000 | $67,000 |
| Change In Account Payable | $355,000 | $-63,000 | $25,000 | $67,000 |
| Change In Prepaid Assets | $237,000 | $857,000 | $-188,000 | $-523,000 |
| Change In Inventory | $-1,074,000 | $2,263,000 | $1,459,000 | $-5,568,000 |
| Change In Receivables | $-1,318,000 | $-2,035,000 | $3,971,000 | $2,015,000 |
| Changes In Account Receivables | $-1,318,000 | $-2,035,000 | $-3,574,000 | $1,918,000 |
| Other Non Cash Items | $1,042,000 | $1,269,000 | $632,000 | - |
| Stock Based Compensation | $2,001,000 | $4,013,000 | $5,114,000 | $6,697,000 |
| Provisionand Write Offof Assets | $978,000 | $863,000 | $1,063,000 | $553,000 |
| Depreciation Amortization Depletion | $655,000 | $599,000 | $692,000 | $890,000 |
| Depreciation And Amortization | $655,000 | $599,000 | $692,000 | $890,000 |
| Gain Loss On Sale Of PPE | $19,000 | $13,000 | $-2,531,000 | $75,000 |
| Net Income From Continuing Operations | $-11,105,000 | $-23,559,000 | $-18,850,000 | $-23,278,000 |
| Issuance Of Debt | - | $0 | $46,106,000 | $0 |
| Long Term Debt Issuance | - | $0 | $46,106,000 | $0 |
| Sale Of PPE | - | $0 | $7,267,000 | $0 |
Fetched: 2026-05-26